Outcome Following Carbon Monoxide Poisoning in Children (CO PED)

March 15, 2011 updated by: Intermountain Health Care, Inc.

Carbon monoxide poisoning is common. Many adults with CO poisoning have long-term, even permanent brain injury following poisoning. However, very little is known about the long-term outcome of children with carbon monoxide (CO) poisoning. In this study we plan to perform cognitive (thinking) and vestibular (balance) testing in children (ages 6 to 16)at 6 weeks and 6 months following CO poisoning.

At the 6-week visit, if the child and parents agree, we will ask each child to provide a DNA sample by one of three methods: mouthwash, spit collection, or swabbing the inside of the child's cheek. Each child's DNA will be analyzed for genes that are known to affect outcome following brain injury.

Study Overview

Status

Terminated

Detailed Description

Each child's participation in this study is expected to last 6 months. Testing will be scheduled around 6 weeks after the carbon monoxide (CO) poisoning episode. During testing, each child will be asked to complete tests that measure cognitive (thinking), emotional, and behavioral performance. We will collect information from each child's medical record about the CO poisoning episode, and we will have a parent complete a questionnaire about any problems he or she may have observed in their child since the poisoning. The cognitive testing will take about 3.5 hours at the 6-week interval, and 2.5 hours at the 6-month interval.

Around the same time, each child will also be scheduled for vestibular (balance) testing at the Intermountain Hearing and Balance Center. Vestibular testing will occur twice, at 6-weeks and 6-months following poisoning.

At the 6-week visit, if the child and parents agree, we will ask each child to provide a DNA sample by one of three methods: mouthwash, spit collection, or swabbing the inside of the child's cheek. Each child's DNA will be analyzed for genes that are known to affect outcome following brain injury such as apolipoprotein E, and the sample will also be stored for an indefinite period of time. If discoveries are made about other genes that affect outcome following brain injury, each child's DNA will be analyzed for those genes as well.

The primary outcome measure will be the percentage of patients with cognitive sequelae (thinking complications or results) at 6 weeks and 6 months following CO poisoning.

Secondarily, we will also determine:

  1. Which individual neurocognitive (thinking) outcomes at 6 weeks and 6 months differ from normative data.
  2. Whether there is a difference in neurocognitive (thinking) outcomes between measurement at 6 weeks and 6 months.
  3. If there is a difference in the vestibular (balance) health of patients between measurements at 6 weeks and 6 months.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84143
        • Intermountain Healthcare, LDS Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children, ages 6-16, following CO poisoning

Description

Inclusion Criteria:

  1. Age 6 through 16.
  2. Acute carbon monoxide poisoning. Since we will be identifying potentially eligible patients using an electronic tool, the diagnosis of CO poisoning should be established by the evaluating physician. However, with the initial contact with the patients' parents, we will confirm the diagnosis, and only those patients with CO poisoning will be eligible.
  3. Willing to come to Salt Lake City or Provo for evaluation

Exclusion Criteria:

  1. Prior history of neurological injury with permanent sequelae.
  2. Prior history of chronic neurological disorder such as attention deficit disorder, learning disability, multiple sclerosis, cerebral palsy, demyelinating disease, meningitis with sequelae
  3. Insulin dependent diabetes (due to the confound of possible brain microvascular disease and episodes of hypoglycemia)
  4. Use of illicit drugs
  5. Use of alcohol in excess
  6. Pregnancy
  7. Carbon monoxide poisoning from a suicide attempt or concomitant smoke inhalation
  8. Subject or parent/guardian non-English-speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
CO poisoned children
Children, ages 6-16, who have been poisoned by carbon monoxide

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of patients with cognitive sequelae at 6 weeks and 6 months following CO poisoning will be reported.
Time Frame: 6 weeks and 6 months after carbon monoxide poisoning incident.
6 weeks and 6 months after carbon monoxide poisoning incident.

Secondary Outcome Measures

Outcome Measure
Time Frame
To determine which individual neurocognitive outcomes at 6 weeks and 6 months differ from normative data.
Time Frame: 6 weeks and 6 months after carbon monoxide poisoning incident.
6 weeks and 6 months after carbon monoxide poisoning incident.
To determine whether there is a difference in neurocognitive outcomes between measurement at 6 weeks and 6 months.
Time Frame: 6 weeks and 6 months after carbon monoxide poisoning incident.
6 weeks and 6 months after carbon monoxide poisoning incident.
To determine if there is a difference in the vestibular health of patients between measurements at 6 weeks and 6 months.
Time Frame: 6 weeks and 6 months after carbon monoxide poisoning incident.
6 weeks and 6 months after carbon monoxide poisoning incident.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Lindell K Weaver, MD, Intermountain Healthcare, LDSH Hyperbaric Medicine
  • Principal Investigator: Susan Churchill, APRN-NP, Intermountain Healthcare, LDSH Hyperbaric Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2007

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

December 1, 2010

Study Registration Dates

First Submitted

January 28, 2010

First Submitted That Met QC Criteria

January 28, 2010

First Posted (Estimate)

February 1, 2010

Study Record Updates

Last Update Posted (Estimate)

March 17, 2011

Last Update Submitted That Met QC Criteria

March 15, 2011

Last Verified

March 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carbon Monoxide Poisoning

3
Subscribe